Press Releases

GUANGZHOU, China, Feb. 28, 2020 /PRNewswire/ -- Since the emergence of new COVID-19 coronavirus outbreak in China, XAG has leveraged its world-leading agriculture technology and pledged 5-million-yuan special fund for epidemic containment. XPlanet drones and R80 robots have been deployed by XAG to disin

NEW YORK, Feb. 28, 2020 /PRNewswire/ -- Dr. Dennis Gross, a New York City board-certified dermatologist with a background in skin cancer research, released a statement citing concerns after a new study published by the Food and Drug Administration (FDA) showed six common chemical sunscreen ingredients absor

LONDON, Feb. 28, 2020 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, today announced that its management will present a corporate overview at the Cowen and Company 40th Annual Health Care Conference at 12 p.m. ET o

COLLEGE STATION, Texas, Feb. 28, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and manufacture of their biologics, vaccines and gene therapies&nbs

FRAMINGHAM, Mass., Feb. 28, 2020 /PRNewswire/ -- Temescal Wellness, the life cannabis company, today announced the launch of recreational online pre-order and expre

PALM BEACH, Florida, Feb. 28, 2020 /PRNewswire/ -- How the first hours, days and weeks of a potential terror or biological attack or the rise of a new infectious disease are managed, has a huge impact on the outcome. The quicker it is identified, the faster the wheels will turn in looking to prevent, contain and cure or eradicate its effects. An article on Infection Con

LOS ANGELES, Feb. 28, 2020 /PRNewswire/ -- USA News Group – While it has not yet been tested in patients, researchers say an accidental T-cell discovery represents "an exciting new frontier" in ca

LOS ANGELES, Feb. 28, 2020 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today clarified certain prior disclosures regarding its relationship with Orphazyme A/S. As previously reported, in 2011 CytRx agreed to sell and transfer certain data,

NEW YORK, Feb. 28, 2020 /PRNewswire/ -- Royalty Pharma announced today that Chris Hite has agreed to join the Company as Executive Vice President and Vice Chairman. Chris joined Citi as Global Head of Healthcare Investment Banking in 2008 and most recently served as Vice Chairman and Global Head of Healthcare. Previously, Chris

REDWOOD CITY, Calif., Feb. 28, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against Nalu Medical, Inc.  The lawsuit, filed in the United States